Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CDK4 overexpression
i
Other names:
CDK4, PSK-J3, Cyclin-dependent kinase 4
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1019
Related biomarkers:
Expression
Mutation
CNA
Others
‹
›
Associations
(6)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. (PalboSarc) (NCT03242382)
Phase 2
Grupo Espanol de Investigacion en Sarcomas
Grupo Espanol de Investigacion en Sarcomas
Recruiting
Phase 2
Grupo Espanol de Investigacion en Sarcomas
Recruiting
Last update posted :
01/23/2024
Initiation :
03/31/2017
Primary completion :
09/30/2024
Completion :
09/30/2024
CDKN2A • CDK4
|
CDKN2A mutation • CDK4 overexpression
|
Ibrance (palbociclib)
A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET) (PALBONET) (NCT02806648)
Phase 2
Grupo Espanol de Tumores Neuroendocrinos
Grupo Espanol de Tumores Neuroendocrinos
Completed
Phase 2
Grupo Espanol de Tumores Neuroendocrinos
Completed
Last update posted :
01/23/2018
Initiation :
05/01/2015
Primary completion :
07/01/2017
Completion :
01/01/2018
RB1 • CCND1 • CDK4 • CDK6
|
CCND1 overexpression • CDK4 overexpression • RB1 overexpression • CDK6 expression
|
Ibrance (palbociclib)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login